Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening
Open accessThe DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index.
Abstract
The recent advent of robust methods to grow human tissues as 3D organoids allows us to recapitulate the 3D architecture of tumors in an in vitro setting and offers a new orthogonal approach for drug discovery. However, organoid culturing with extracellular matrix to support 3D architecture has been challenging for high-throughput screening (HTS)-based drug discovery due to technical difficulties. Using genetically engineered human colon organoids as a model system, here we report our effort to miniaturize such 3D organoid culture with extracellular matrix support in high-density plates to enable HTS. We first established organoid culturing in a 384-well plate format and validated its application in a cell viability HTS assay by screening a 2036-compound library. We further miniaturized the 3D organoid culturing in a 1536-well ultra-HTS format and demonstrated its robust performance for large-scale primary compound screening. Our miniaturized organoid culturing method may be adapted to other types of organoids. By leveraging the power of 3D organoid culture in a high-density plate format, we provide a physiologically relevant screening platform to model tumors to accelerate organoid-based research and drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The size of these organ-like structures ranges from 100 µm (lung organoid) to 2 mm (brain organoid) and they can be cultivated in small dimensions (for example, 96-well or 384-well plates25,26), thereby being suitable for high-throughput screening.”
From Human disease models in drug development (2023) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Zhang, J.-H., Chung, T. D. Y., & Oldenburg, K. R. (1999) · SLAS Discovery · doi:10.1177/108705719900400206 · Cited by 6,847 · cited 2×
“0 indicates that the assay is robust for HTS (Zhang et al., 1999).”
BackgroundModeling Development and Disease with Organoids
Clevers, H. (2016) · Cell · doi:10.1016/j.cell.2016.05.082 · Cited by 3,196 · cited 2×
“Compared to the traditional 2D culture using transformed cell lines, primary organoids have the advantage of retaining the characteristics of the cancer cells from the original patient’s tissue, including their differentiated morphology and response to drugs (Clevers, 2016; Weeber et al., 2017; Abbasi, 2018; Sachs et…”
BackgroundThe Genomic Landscapes of Human Breast and Colorectal Cancers
Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjöblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J., et al. (2007) · Science · doi:10.1126/science.1145720 · Cited by 2,833
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
van de Wetering, M., Francies, H. E., Francis, J. M., Bounova, G., Iorio, F., Pronk, A., van Houdt, W., van Gorp, J., Taylor-Weiner, A., Kester, L., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.053 · Cited by 2,408
The Clinical KRAS(G12C) Inhibitor AMG 510 Drives Anti-Tumour Immunity
Canon, J., Rex, K., Saiki, A. Y., Mohr, C., Cooke, K., Bagal, D., Gaida, K., Holt, T., Knutson, C. G., Koppada, N., et al. (2019) · Nature · doi:10.1038/s41586-019-1694-1 · Cited by 2,277 · cited 1×
“Attempts to develop targeted therapies for this genomic subset of patients have been largely unsuccessful, although therapeutic targeting of KRAS tumors has now advanced to phase II clinical trials, offering much hope for patients (Canon et al., 2019).”
BackgroundPatient-derived organoids model treatment response of metastatic gastrointestinal cancers
Vlachogiannis, G., Hedayat, S., Vatsiou, A., Jamin, Y., Fernández-Mateos, J., Khan, K., Lampis, A., Eason, K., Huntingford, I., Burke, R., et al. (2018) · Science · doi:10.1126/science.aao2774 · Cited by 2,096 · cited 3×
“Compared to the traditional 2D culture using transformed cell lines, primary organoids have the advantage of retaining the characteristics of the cancer cells from the original patient’s tissue, including their differentiated morphology and response to drugs (Clevers, 2016; Weeber et al., 2017; Abbasi, 2018; Sachs et…”
BackgroundA living biobank of breast cancer organoids captures disease heterogeneity
Sachs, N., de Ligt, J., Kopper, O., Gogola, E., Bounova, G., Weeber, F., Balgobind, A. V., Wind, K., Gracanin, A., Begthel, H., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.010 · Cited by 1,973 · cited 8×
“Currently, only small scales, e.g. <100 compounds, have been tested as proof-of-concept to exam the response of 3D organoids in ECM to drugs (Gao et al., 2014; van de Wetering et al., 2015; Schutte et al., 2017; Sachs et al., 2018; Li et al., 2019).”
BackgroundMethodResultInfluentialDrost, J., & Clevers, H. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0007-6 · Cited by 1,790 · cited 1×
“They represent near-physiological models for use in both basic and translational research (Drost and Clevers, 2018; Yang et al., 2018; Castellon, 2019; Kim et al., 2019).”
MethodOrganoid Cultures Derived from Patients with Advanced Prostate Cancer
Gao, D., Vela, I., Sboner, A., Iaquinta, P. J., Karthaus, W. R., Gopalan, A., Dowling, C., Wanjala, J. N., Undvall, E. A., Arora, V. K., et al. (2014) · Cell · doi:10.1016/j.cell.2014.08.016 · Cited by 1,559
Cited by
Human disease models in drug development
Loewa, A., Feng, J. J., & Hedtrich, S. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00063-3 · Cited by 331
Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
Wensink, G. E., Elias, S. G., Mullenders, J., Koopman, M., Boj, S. F., Kranenburg, O. W., & Roodhart, J. M. L. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00168-1 · Cited by 323
Applications of organoids for cancer biology and precision medicine
Lo, Y.-H., Karlsson, K., & Kuo, C. J. (2020) · Nature Cancer · doi:10.1038/s43018-020-0102-y · Cited by 182
Self-citationAdvances in artificial intelligence for drug delivery and development: A comprehensive review
Gholap, A. D., Uddin, M. J., Faiyazuddin, M., Omri, A., Gowri, S., & Khalid, M. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108702 · Cited by 179
3D cell cultures toward quantitative high-throughput drug screening
Wang, Y., & Jeon, H. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.03.014 · Cited by 157
DrugComb update: a more comprehensive drug sensitivity data repository and analysis portal
Zheng, S., Aldahdooh, J., Shadbahr, T., Wang, Y., Aldahdooh, D., Bao, J., Wang, W., & Tang, J. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab438 · Cited by 127
Seidlitz, T., Koo, B.-K., & Stange, D. E. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-020-00662-2 · Cited by 108
Organoids in image-based phenotypic chemical screens
Lukonin, I., Zinner, M., & Liberali, P. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00641-8 · Cited by 99
Patient-derived organoids in translational oncology and drug screening
Yang, R., & Yu, Y. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216180 · Cited by 99
Shi, H., Kowalczewski, A. C., Vu, D., Liu, X., Salekin, A., Yang, H., & Ma, Z. (2023) · Medicine in Novel Technology and Devices · doi:10.1016/j.medntd.2023.100276 · Cited by 118
Enabling peristalsis of human colon tumor organoids on microfluidic chips
Fang, G., Lu, H., Al-Nakashli, R., Chapman, R., Zhang, Y., Ju, L. A., Lin, G., Stenzel, M. H., & Jin, D. (2022) · Biofabrication · doi:10.1088/1758-5090/ac2ef9 · Cited by 77
Organoids in high-throughput and high-content screenings
Lampart, F. L., Iber, D., & Doumpas, N. (2023) · Frontiers in Chemical Engineering · doi:10.3389/fceng.2023.1120348 · Cited by 66
Advanced lung organoids for respiratory system and pulmonary disease modeling
Joo, H., Min, S., & Cho, S. (2024) · Journal of Tissue Engineering · doi:10.1177/20417314241232502 · Cited by 69
Li, Y., Lin, Z., Wang, Y., Ju, S., Wu, H., Jin, H., Ma, S., & Zhang, B. (2022) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2022.104302 · Cited by 56
Organoid Imaging: Seeing Development and Function
Keshara, R., Kim, Y. H., & Grapin‐Botton, A. (2022) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-120320-035146 · Cited by 57
Gastrointestinal cancer organoids—applications in basic and translational cancer research
Seidlitz, T., & Stange, D. E. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00654-3 · Cited by 58
Reconstructing the tumor architecture into organoids
Luo, Z., Zhou, X., Mandal, K., He, N., Wennerberg, W., Qu, M., Jiang, X., Sun, W., & Khademhosseini, A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113839 · Cited by 52
The Molecular Mechanisms of Intestinal Inflammation and Fibrosis in Crohn’s Disease
Hayashi, Y., & Nakase, H. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.845078 · Cited by 53
Everything You Always Wanted to Know About Organoid-Based Models (and Never Dared to Ask)
Hautefort, I., Poletti, M., Papp, D., & Korcsmáros, T. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.04.012 · Cited by 53
Flourishing tumor organoids: History, emerging technology, and application
Yang, Q., Li, M., Yang, X., Xiao, Z., Tong, X., Tuerdi, A., Li, S., & Lei, L. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10559 · Cited by 48
Shrestha, S., Lekkala, V. K. R., Acharya, P., Kang, S., Vanga, M. G., & Lee, M. (2024) · Lab on a Chip · doi:10.1039/d4lc00149d · Cited by 42
deepOrganoid: a brightfield cell viability model for screening matrix-embedded organoids
Powell, R. T., Moussalli, M. J., Guo, L., Bae, G., Singh, P., Stephan, C., Shureiqi, I., & Davies, P. J. (2022) · SLAS Discovery · doi:10.1016/j.slasd.2022.03.004 · Cited by 37
Organoids meet microfluidics: recent advancements, challenges, and future of organoids-on-chip
Chauhdari, T., Zaidi, S. A., Su, J., & Ding, Y. (2025) · In vitro models · doi:10.1007/s44164-025-00086-7 · Cited by 45
Spelier, S., de Poel, E., Ithakisiou, G. N., Suen, S. W. F., Hagemeijer, M. C., Muilwijk, D., Vonk, A. M., Brunsveld, J. E., Kruisselbrink, E., van der Ent, C. K., et al. (2022) · ERJ Open Research · doi:10.1183/23120541.00495-2022 · Cited by 39
Osteochondral organoids: current advances, applications, and upcoming challenges
Faeed, M., Ghiasvand, M., Fareghzadeh, B., & Taghiyar, L. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03790-5 · Cited by 38
Kalla, J., Pfneissl, J., Mair, T., Tran, L., & Egger, G. (2024) · Cellular Oncology · doi:10.1007/s13402-024-00960-8 · Cited by 33
High-throughput solutions in tumor organoids: from culture to drug screening
Zuo, J., Fang, Y., Wang, R., & Liang, S. (2024) · Stem Cells · doi:10.1093/stmcls/sxae070 · Cited by 33
The Patient-Derived Cancer Organoids: Promises and Challenges as Platforms for Cancer Discovery
Bae, J., Choi, Y. S., Cho, G., & Jang, S. J. (2022) · Cancers · doi:10.3390/cancers14092144 · Cited by 27
Advancements in Organoid‐Based Drug Discovery: Revolutionizing Precision Medicine and Pharmacology
Singh, D., Thakur, A., Rakesh, & Kumar, A. A. (2025) · Drug Development Research · doi:10.1002/ddr.70121 · Cited by 30
Ma, C., Seong, H., Li, X., Yu, X., Xu, S., & Li, Y. (2022) · Stem Cells International · doi:10.1155/2022/2150680 · Cited by 30
Self-citationLiverani, C., Vita, A. D., Spadazzi, C., Miserocchi, G., Cocchi, C., Bongiovanni, A., Lucia, A. D., Manna, F. L., Fabbri, F., Tebaldi, M., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13037 · Cited by 25
Revealing the clinical potential of high-resolution organoids
Ko, J., Hyung, S., Cheong, S., Chung, Y., & Jeon, N. L. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115202 · Cited by 24
Advances in organoid-on-a-chip for recapitulation of human physiological events
Park, B. J., Park, J., Han, S., Kwon, T., Sung, J. Y., Kim, J., Safarkhani, M., Min, K.-H., Lee, E.-H., Kang, S., et al. (2025) · Materials Today · doi:10.1016/j.mattod.2025.02.002 · Cited by 23
An off-the-shelf multi-well scaffold-supported platform for tumour organoid-based tissues
Li, N. T., Wu, N. C., Cao, R., Cadavid, J. L., Latour, S., Lu, X., Zhu, Y., Mijalkovic, M., Roozitalab, R., Landon‐Brace, N., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121883 · Cited by 24
Jung, Y. H., Park, K., Kim, M., Oh, H., Choi, D., Ahn, J.-C., Lee, S.-B., Na, K., Min, B. S., Kim, J.-A., et al. (2023) · BioChip Journal · doi:10.1007/s13206-023-00099-y · Cited by 22
Light-field tomographic fluorescence lifetime imaging microscopy
Ma, Y., Park, J., Huang, L., Sen, C., Burri, S., Bruschini, C. E., Yang, X., Cui, Q., Cameron, R. B., Fishbein, G. A., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2402556121 · Cited by 20
Takahashi, N., Higa, A., Hiyama, G., Tamura, H., Hoshi, H., Dobashi, Y., Katahira, K., Ishihara, H., Takagi, K., Goda, K., et al. (2021) · Oncology Letters · doi:10.3892/ol.2021.12667 · Cited by 19
Development of patient derived organoids for cancer drug screening applications
Baskar, G., Palaniyandi, T., Viswanathan, S., Rajendran, B. K., Ravi, M., & Sivaji, A. (2022) · Acta Histochemica · doi:10.1016/j.acthis.2022.151895 · Cited by 19
Harnessing Organoid Platforms for Nanoparticle Drug Development
Chen, L., Luo, X., Zhang, J., Zhang, J., Yang, C., & Zhao, Y. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s530999 · Cited by 21
3D microgels to quantify tumor cell properties and therapy response dynamics
Wu, N. C., Cadavid, J. L., Tan, X., Latour, S., Scaini, S., Makhijani, P., McGaha, T. L., Ailles, L., & McGuigan, A. P. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121417 · Cited by 18
Combination of multiple omics techniques for a personalized therapy or treatment selection
Massa, C., & Seliger, B. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1258013 · Cited by 20
Advances in the application of colorectal cancer organoids in precision medicine
Zhang, Y., Meng, R., Sha, D., Gao, H., Wang, S., Zhou, J., Wang, X., Li, F., Li, X., & Song, W. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1506606 · Cited by 19
Self-citationSkeletal muscle, neuromuscular organoids and assembloids: a scoping review
Yang, J.-L., Qian, S.-Y., Chen, M.-L., Wang, L., Wang, Y., Liu, J., Xi, C., Yang, Y., Li, Y., Gao, C., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105825 · Cited by 21
Tumor Organoids as a Research Tool: How to Exploit Them
Booij, T. H., Cattaneo, C. M., & Hirt, C. (2022) · Cells · doi:10.3390/cells11213440 · Cited by 17
de Villiers, M., Kotzé, A. F., & Plessis, D. (2024) · Biomedical Materials · doi:10.1088/1748-605x/ad651f · Cited by 19
Huang, T. H., Huang, W. T., & Bian, Q. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114222 · Cited by 14
Jörg, M., & Madden, K. S. (2021) · RSC Medicinal Chemistry · doi:10.1039/d1md00022e · Cited by 15
Organoid models of the pituitary gland in health and disease
Laporte, E., & Vankelecom, H. E. J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1233714 · Cited by 17
Functional screening of amplification outlier oncogenes in organoid models of early tumorigenesis
Salahudeen, A. A., Seoane, J. A., Yuki, K., Mah, A. T., Smith, A. R., Kolahi, K. S., Sean de la, O., Hart, D. J., Ding, J., Ma, Z., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113355 · Cited by 14
Self-citationLi, J., Liu, J., Xia, W., Yang, H., Sha, W., & Chen, H. H. (2024) · Technology in Cancer Research & Treatment · doi:10.1177/15330338231221856 · Cited by 15
Utilization of intestinal organoid models for assessment of micro/nano plastic-induced toxicity
Yuan, Q., & Liu, Y. (2023) · Frontiers in Environmental Science · doi:10.3389/fenvs.2023.1285536 · Cited by 14
Three-Dimensional Scaffolds for Intestinal Cell Culture: Fabrication, Utilization, and Prospects
Liu, T., Gu, J. L., Fu, C., & Su, L. (2024) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2023.0124 · Cited by 13
Hong, C., & Lyu, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157247 · Cited by 18
Modeling colorectal cancers using multidimensional organoids
Sayed, I. M., El‐Hafeez, A. A. A., Maity, P. P., Das, S., & Ghosh, P. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.02.005 · Cited by 13
High-Throughput Live and Fixed Cell Imaging Method to Screen Matrigel-Embedded Organoids
Ramm, S., Vary, R., Gulati, T., Luu, J., Cowley, K. J., Janes, M. S., Radio, N. M., & Simpson, K. J. (2022) · Organoids · doi:10.3390/organoids2010001 · Cited by 13
Silvestri, A., Vicente, F., Vicent, M. J., Stechmann, B., & Fecke, W. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.02.024 · Cited by 14
Larsen, B. M., Cancino, A., Shaxted, J. M., & Salahudeen, A. A. (2022) · STAR Protocols · doi:10.1016/j.xpro.2022.101407 · Cited by 12
Melcón-Fernández, E., Galli, G., Balaña‐Fouce, R., García-Fernández, N., Valladares, M. M., Reguera, R. M., García‐Estrada, C., & Pérez‐Pertejo, Y. (2024) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed9020030 · Cited by 11
Shu, C., Li, J., Rui, J., Fan, D., Niu, Q., Bai, R., Cicka, D., Doyle, S. P., Wahafu, A., Zheng, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57297-5 · Cited by 13
Self-citationColorectal Organoids: Models, Imaging, Omics, Therapy, Immunology, and Ethics
Taglieri, M., Gregorio, L. D., Matis, S., Uras, C. R. M., Ardy, M., Casati, S., Marchese, M., Poggi, A. D., Raffaghello, L., & Benelli, R. (2025) · Cells · doi:10.3390/cells14060457 · Cited by 13
Yang, J., Yang, Y., Xu, P., Yao, Y., Tian, H., Wang, X., Fang, H., Ge, S., Yao, Y., Wang, Y., et al. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002530 · Cited by 13
Xu, Z., Yang, H., Zhou, Y., Dzakah, E. E., & Zhao, B. T. (2025) · Life Medicine · doi:10.1093/lifemedi/lnaf021 · Cited by 15
Havnar, C. A., Holokai, L. L., Ichikawa, R., Chen, W., Scherl, A., & Shamir, E. R. (2024) · Journal of Histotechnology · doi:10.1080/01478885.2024.2398381 · Cited by 10
Organoid modeling meets cancers of female reproductive tract
Li, J., Zhou, M., Xie, J. H., Chen, J., Yang, M., Ye, C., Cheng, S., Liu, M., Li, R., & Tan, R. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02186-x · Cited by 9
Patil, S., Yu, S., Jobby, R., Ravichandran, V., & Sarkar, S. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1516237 · Cited by 12
Singh, Y. P., Moses, J. C., Kim, M.-H., Gupta, D., Pal, V., Deniz, I. D., Gerhard, E. M., & Ozbolat, I. T. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.11.024 · Cited by 22
Ghosh, A. K., Ghosh, S., Pati, F., & Duraiswamy, S. (2023) · Bioprinting · doi:10.1016/j.bprint.2023.e00316 · Cited by 9
Soto, J., Linsley, C. S., Song, Y., Chen, B., Fang, J., Neyyan, J., Davila, R., Lee, B. S., Wu, B. M., & Li, S. (2023) · Nanomaterials · doi:10.3390/nano13172455 · Cited by 9
Emerging drug targets for triple-negative breast cancer: a guided tour of the preclinical landscape
Xie, X., Lee, J., Iwase, T., Kai, M., & Ueno, N. T. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2077188 · Cited by 12
Potential Application of Intestinal Organoids in Intestinal Diseases
Liu, W., Wang, Q., Bai, Y., Xiao, H., Li, Z., Wang, Q., Yang, J., Yang, J., & Sun, H. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10651-w · Cited by 8
Protocol for high throughput 3D drug screening of patient derived melanoma and renal cell carcinoma
Jordan, L. M. O., Vega, V. F., Shumate, J., Peles, A., Zeiger, J., Scampavia, L. D., & Spicer, T. (2024) · SLAS DISCOVERY · doi:10.1016/j.slasd.2024.01.002 · Cited by 8
New benzimidazole derivative compounds with in vitro fasciolicidal properties
Valderas-García, E., de Agüero, V. C. G., del Palacio, L. G., Galli, G., Escala, N., Ruiz-Somacarrera, M., González–Warleta, M., del Olmo, E., Balaña‐Fouce, R., & Valladares, M. M. (2024) · Parasites & Vectors · doi:10.1186/s13071-024-06224-6 · Cited by 7
Developments in gastrointestinal organoid cultures to recapitulate tissue environments
Kuhn, M. R., Wolcott, E. A., & Langer, E. M. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1521044 · Cited by 10
Rahman, M. M., Wells, G., Rantala, J., Helleday, T., Muthana, M., & Danson, S. J. (2024) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2024.2336583 · Cited by 7
Precision Medicine for Gastric Cancer: Current State of Organoid Drug Testing
Silva, T. N., Wright, J. A., Worthley, D. L., & Woods, S. L. (2024) · Organoids · doi:10.3390/organoids3040016 · Cited by 6
Ingenious integration of synthetic biology and droplet microfluidics
Zhang, P., Wu, H., Zhang, R., Zhao, D., Wei, W., Yang, Q., Wang, Z., Shi, T., & Wang, Y. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.165813 · Cited by 11
3D cell culture model – a substitution for future in vivo fish study?
Ranasinghe, N., Lee, S.-S., Gamage, L., & Lee, T. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10821-8 · Cited by 6
Emerging trends in computational approaches for drug discovery in molecular biology
Yuguda, Y. M., Unuebho, I. E., kolli, T., & Dhanushya, J. (2023) · GSC Biological and Pharmaceutical Sciences · doi:10.30574/gscbps.2023.24.3.0340 · Cited by 7
Role of Genomics and Proteomics in Drug Discovery
Sundarasekar, J., & Sahgal, G. (2024) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-97-1148-2_11 · Cited by 6
Cell fiber-based 3D tissue array for drug response assay
Kato‐Negishi, M., Sawayama, J., Kawahara, M., & Takeuchi, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-11670-2 · Cited by 6
Galli, G., Melcón-Fernández, E., García, M. G. D. G., Martínez-Fernández, B., Dehnavi, M., Andrés, S., Pérez‐Pertejo, Y., Reguera, R. M., García‐Estrada, C., Valladares, M. M., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073452 · Cited by 8
Xiu, Z., Yang, Q., Xie, F., Han, F., He, W., & Liao, W. (2024) · Journal of Tissue Engineering · doi:10.1177/20417314241255470 · Cited by 6
Randall‐Demllo, S., Al-Qadami, G. H., Raposo, A. E., Ma, C., Priebe, I. K., Hor, M., Singh, R., & Fung, K. Y. C. (2024) · Cancers · doi:10.3390/cancers16213664 · Cited by 6
Harmych, S. J., Hasaka, T. P., Sievers, C. K., Kang, S. W., Ramirez, M. A., Jones, V. T., Zhao, Z., Kovtun, O., Wahoski, C. C., Liu, Q., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08699-0 · Cited by 4
Antileishmanial Effect of 1,5- and 1,8-Substituted Fused Naphthyridines
Melcón-Fernández, E., Martín‐Encinas, E., Palácios, F., Galli, G., Reguera, R. M., Valladares, M. M., Balaña‐Fouce, R., Alonso, C., & Pérez‐Pertejo, Y. (2023) · Molecules · doi:10.3390/molecules29010074 · Cited by 5
Joo, S. S., Gu, B., Lee, E., Oh, E., Kim, M., Jung, H.-J., & Kim, M. (2026) · Journal of Animal Science and Technology · doi:10.5187/jast.2024.e116 · Cited by 4
Keleş, B. S., Rumman, B., Samarie, M. A. J. A., Özdemir, Y., Çakmak, Ö. Ö., Akyoldaş, G., Ertan, S., & Sokullu, E. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02461-z · Cited by 4
Floyd, H. E. E., de Paula, M. N., Sen, T., Kavanagh, A. M., Zuegg, J., & Blaskovich, M. A. T. (2026) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2026.2679706 · Cited by 4
Cox, M. C., Mendes, R. G. P. R., Halwachs, K. N., Domenici, G., Brito, C., & Boghaert, E. R. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2216016 · Cited by 3
In vitro toxicity assessment of graphene quantum dots using a 3D HepG2 model
Durmišević, I., Haverić, A., Žabkar, S., Štern, A., Kološa, K., Belec, P. J., Ćetković, T., Omanović, M. H., Gutić, S. J., Rozman, I. M., et al. (2026) · Archives of Toxicology · doi:10.1007/s00204-026-04336-9 · Cited by 4
High-throughput screening for novel drug combinations using patient-derived organoids
Thielen, N., Kuang, C., Chu, E., & Wei, N. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118090 · Cited by 2
Hu, Z., Liao, Y., Niu, M., Kong, Z., Vankelecom, H. E. J., Cheng, J., Deleidi, M., Li, C., Jiang, Z., Bian, S., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.05.032 · Cited by 3
Stelzer, N., Ort, M., Händler, K., Bortel, E. L., Dimitriou, I. M., Textor, M., Duda, G. N., Schoon, J., Marx, U., Kornak, U., et al. (2026) · Advanced Science · doi:10.1002/advs.202518224 · Cited by 2
A strategy to enhance SERS detection sensitivity through the use of SiO2 beads in a 1536-well plate
Chen, J., Yu, Q., Lu, M., Jeon, C. S., Pyun, S. H., & Choo, J. (2023) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-023-04896-0 · Cited by 3
Fabrication and Optimization of 3D-Printed Silica Scaffolds for Neural Precursor Cell Cultivation
Kastrinaki, G., Pechlivani, E. M., Gkekas, I., Kladovasilakis, N., Gkagkari, E., Petrakis, S., & Asimakopoulou, A. G. (2023) · Journal of Functional Biomaterials · doi:10.3390/jfb14090465 · Cited by 2
Galli, G., Ruiz-Somacarrera, M., del Palacio, L. G., Melcón-Fernández, E., González-Pérez, R., García‐Estrada, C., Valladares, M. M., & Balaña‐Fouce, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041595 · Cited by 4
Shu, C., Jin, R., Niu, Q., Cicka, D., Doyle, S. P., Wahafu, A., Fan, D., Zheng, X., Du, Y., Ivanov, A. A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.17.460294 · Cited by 2
Self-citationDiscovery of Potential Antileishmanial Compounds Through Phenotypic Screening of an Alkaloid Library
Soh-Kamdjo, C., González-Montero, M.-C., García‐Estrada, C., Melcón-Fernández, E., Fernández-Rubio, C., Pérez‐Pertejo, Y., Reguera, R. M., & Balaña‐Fouce, R. (2025) · Molecules · doi:10.3390/molecules30214210 · Cited by 1
Xu, J., Kang, Y. Y., Kedong, S., Fan, J., & Liu, Y. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04655-0 · Cited by 1
Artificial intelligence in multiscale scaffolds for cancer organoids testbed
Katti, D. R., Katti, K. S., Gaikwad, H. K., & Jaswandkar, S. V. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18498-7.00005-3 · Cited by 2
Metadata
- Authors
- Du, Y., Li, X., Niu, Q., Mo, X., Qui, M., Ma, T., Kuo, C. J., & Fu, H.
- Affiliations
- Emory University (US)
- Stanford Medicine (US)
- Corresponding author
- Du, Yuhong
- Venue
- Journal of Molecular Cell Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-07-17
- Volume
- 12
- Issue
- 8
- Pages
- 630-643
- ISSN
- 1674-2788 (ISSN-L)
- 1759-4685
- PMC
- PMC7751183
- OpenAlex
- W3042505563
- Cited by
- 125
- References
- 53
- Citations by year
- 2026: 19 · 2025: 26 · 2024: 24 · 2023: 23 · 2022: 18 · 2021: 13 · 2020: 2
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Molecular Cell Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- NCI Cancer Target Discovery and Development (1U01CA217875, 1U01CA217851)
- RAS Synthetic Lethal Network (1U01CA199241)
- Emory Lung Cancer SPORE
- NIH (P50CA217691, UL1-TR002378)
- Winship Cancer Institute (NIH 5P30CA138292)
- Emory WHSC 10X Single Cell Sequencing Seed Grant
- Emory Woodruff Health Sciences Center Synergy Award
- Imagine, Innovate and Impact
- Funds from the Emory School of Medicine
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Zebrafish Biomedical Research Applications
- Keywords
- 3D organoids, colon organoids, high-throughput screening, ultra-high-throughput screening, 1536-well plates, 384-well plate, extracellular matrix, drug discovery, compound screening, tumor models
- MeSH terms
- Colon, Humans, Miniaturization, Organoids, Cryopreservation, Cell Culture Techniques, Imaging, Three-Dimensional, Cell Shape, High-Throughput Screening Assays
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.